The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pan-cancer mesenchymal assay to predict response to MEK inhibitors.
 
Nuala McCabe
Employment - Almac Diagnostics
Travel, Accommodations, Expenses - Almac Diagnostics
 
Laura A Knight
Employment - Almac Diagnostics
 
Lara Dura Perez
Employment - Almac Diagnostics
 
Bethanie Price
Employment - Almac Diagnostics
 
Andrena McCavigan
Employment - Almac Diagnostics
 
Aya El-Helali
No Relationships to Disclose
 
Sharon Eddie
No Relationships to Disclose
 
Charlie Gourley
Honoraria - AstraZeneca; Cor2Ed; Medscape; Tesaro
Consulting or Advisory Role - AstraZeneca; Cor2Ed; Foundation One Inc (Inst); Nucana (Inst); Roche (Inst); Tesaro (Inst)
Research Funding - Aprea AB (Inst); AstraZeneca (Inst); Novartis (Inst); Nucana (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - One patent issued and four pending for a gene expression signature to predict cancer sensitivity to anti-angiogenic therapy. (Inst)
 
Denis P Harkin
Employment - Almac Diagnostics
Leadership - Almac Diagnostics
 
Richard D. Kennedy
Employment - Almac Diagnostics
Patents, Royalties, Other Intellectual Property - I am an author on the colon cancer prognostic COLDx assay patent